Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Open accessThe DOI matches its Crossref record; 127 of the 129 references it cites were found in a registry or an index.
Abstract
The concept of molecular mimicry was established to explain commonalities of structure which developed in response to evolutionary pressures. Most examples of molecular mimicry in medicine have involved homologies of primary protein structure which cause disease. Molecular mimicry can be expanded beyond amino acid sequence to include microRNA and proteomic effects which are either pathogenic or salutogenic (beneficial) in regard to Parkinson's disease, Alzheimer's disease, and related disorders. Viruses of animal or plant origin may mimic nucleotide sequences of microRNAs and influence protein expression. Both Parkinson's and Alzheimer's diseases involve the formation of transmissible self-propagating prion-like proteins. However, the initiating factors responsible for creation of these misfolded nucleating factors are unknown. Amyloid patterns of protein folding are highly conserved through evolution and are widely distributed in the world. Similarities of tertiary protein structure may be involved in the creation of these prion-like agents through molecular mimicry. Cross-seeding of amyloid misfolding, altered proteostasis, and oxidative stress may be induced by amyloid proteins residing in bacteria in our microbiota in the gut and in the diet. Pathways of molecular mimicry induced processes induced by bacterial amyloid in neurodegeneration may involve TLR 2/1, CD14, and NFκB, among others. Furthermore, priming of the innate immune system by the microbiota may enhance the inflammatory response to cerebral amyloids (such as amyloid-β and α-synuclein). This paper describes the specific molecular pathways of these cross-seeding and neuroinflammatory processes. Evolutionary conservation of proteins provides the opportunity for conserved sequences and structures to influence neurological disease through molecular mimicry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Age-related perturbations in the gut microbiome have emerged as crucial factors contributing to age-related pathological conditions, including chronic inflammation,178 neurodegeneration,179 cognitive decline,180 and type 1 and type 2 diabetes.181”
From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“PD is characterized by accumulation of aggregated and phosphorylated AS in Lewy bodies and Lewy neurites [24] [25] [26].”
BackgroundHost-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · cited 1×
“It is estimated that there are 10X more cells and 130X more DNA in the metagenome than in our own bodies [40] [41].”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Table 2 Agents inducing molecular mimicry REF Bacteria * [9] [44] [56] Animal viruses * [3] Plant viruses * [4] [5] [15] Amyloids proteins in food [50] [56] Bacteria that make amyloid proteins * * Xanthomonas axonopodis * Exogenous as well as endogenous (found in the microbiota).”
BackgroundApolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · cited 1×
“ApoE, as a lipid-handling gene, influences bile acid secretion in humans and mucin secretion in murine lung, and has immunomodulatory effects [112] [113] [114] [115].”
BackgroundGut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 2×
“In particular, the importance of diversity of diet leading to diversity of the microbiota is a new concept, which is clinically important [45] [123].”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · cited 1×
“The production of anti-inflammatory Treg cells may be enhanced by addition of " rationally selected " Clostridia strains [75].”
BackgroundThe gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791 · cited 1×
“Proteins from gut bacteria may gain access to neurons in the myenteric plexus because of the sampling of gut contents by epithelial microfold (M) cells as well as dendritic cells which deliver antigens to immune cells in Peyer’s patches [58, 59].”
Background
Research works printed but not linked: 1
- [103]103. Holmes C (2013) Review: Systemic inflammation and Alzheimer's disease. Neuropathol Appl Neurobiol 39, 51-68.
Cited by
Items 201–300 of 338
Mental Disorders Linked to Crosstalk between The Gut Microbiome and The Brain
Choi, T.-Y., Choi, Y. P., & Koo, J. W. (2020) · Experimental Neurobiology · doi:10.5607/en20047 · Cited by 39
“For example, amyloid, one of the main molecules related to AD, was generated from the gut microbiome [62-64], and acted as an antimicrobial peptide [65, 66].”
BackgroundVersace, S., Pellitteri, G., Sperotto, R., Tartaglia, S., Porto, A. D., Catena, C., Gigli, G. L., Cavarape, A., & Valente, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310615 · Cited by 18
The Evolution of Functional Amyloids and Their Impact on Host–Microbe Interactions
Kolli, D., Rout, S. K., Riek, R., & Chapman, M. R. (2025) · Advanced Science · doi:10.1002/advs.202510109 · Cited by 17
Manole, E., Dumitrescu, L., Niculite, C. M., Popescu, B. O., & Ceafalan, L. C. (2021) · Biocell · doi:10.32604/biocell.2021.013452 · Cited by 15
“(2006) hypothesised that the alphasynuclein misfolding process originates in the nasal mucosa and the gut (Braak et al., 2006; Braak et al., 2003; Friedland, 2015; Hawkes et al., 2007).”
BackgroundLuyckx, T., Grootaert, C., Monge‐Morera, M., Delcour, J. A., Rousseau, F., Schymkowitz, J. W. H., & Camp, J. V. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101032 · Cited by 14
Is the Brain Undernourished in Alzheimer’s Disease?
Aquilani, R., Costa, A. C., Maestri, R., Ramusino, M. C., Perini, G., Boselli, M., Iadarola, P., Buonocore, D., Verri, M., Dossena, M., et al. (2022) · Nutrients · doi:10.3390/nu14091872 · Cited by 15
“The development of insulin resistance [2,3,56] might be favored and/or heightened by gut dysbiosis [57,58] that, via intestinal translocations of bacteria, bacterial amyloids and toxins, may increase cerebral inflammation brought about by Aβ [59].”
BackgroundGut Microorganisms and Neurological Disease Perspectives
Faruqui, N. A., Prium, D. H., Mowna, S. A., Ullah, M. A., Araf, Y., Sarkar, B., Zohora, U. S., & Rahman, M. S. (2021) · Future Neurology · doi:10.2217/fnl-2020-0026 · Cited by 16
Ayan, E. B., DeMirci, H., Serdar, M. A., Palermo, F., & Baykal, A. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612819 · Cited by 16
“gallisepticum subspecies of Tenericutes can hinder the promoter activity of the mRNA–ribosome complex, thereby inducing significant modifications in the translatome in the presence of stressors [52].”
BackgroundYao, L., Yang, Y., Yang, X., & Rezaei, M. J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04151-2 · Cited by 16
“Molecular mimicry is a process in which self-antigens and foreign antigens share similarities in nucleotide sequences or structural characteristics [119].”
Nutrigenomics and neurological disorders: exploring diet-brain interactions for cognitive health
Waheed, A., Ghaffar, M., Mustafa, S., Abbas, A., Khan, S. I., Waheed, A., & Naz, H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00791-7 · Cited by 17
“A lot of Bacterium species produce Aβ plaques, like E.coli, Bacillus subtilis, Mycobacterium species, and Staphylococcus aureus [81].”
Zafari, R., Goudarzi, N., Kamroo, A., Tafti, M. F., Ghorbani, A., Talebian, N., Najafi, S., Shahbazian, S., Rahmanian, M., Parvardeh, S., et al. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-01022-y · Cited by 15
“Such disruptions can contribute to NDDs through multiple pathways, including immune system dysfunction, increased permeability of the BBB, and neuroinflammation triggered by neurotoxin release [59, 60].”
Ex vivo Detection of Amyloid-β in Naturally Formed Oral Biofilm
Kanagasingam, S., von Ruhland, C. J., Welbury, R. R., & Singhrao, S. K. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220076 · Cited by 13
“Friedland [23] suggests a sinister role for the microbial amyloids because they may impose a potential risk for AD development through the phenomenon known as cross-seeding.”
BackgroundMutant and curli-producing E. coli enhance the disease phenotype in a hSOD1-G93A mouse model of ALS
Kurlawala, Z., McMillan, J. D., Singhal, R. A., Morehouse, J. R., Burke, D. A., Sears, S. M., Duregon, E., Beverly, L. J., Siskind, L. J., & Friedland, R. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-32594-5 · Cited by 12
Self-citationThe Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
Dhanawat, M., Garima, G., Wilson, K., Gupta, S., Gupta, N., & Sardana, S. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273302508240613114103 · Cited by 13
Thakur, P., Baraskar, K., Shrivastava, V. K., & Medhi, B. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149176 · Cited by 12
The Role of Probiotics in Modulating the Gut Microbiome in Alzheimer’s Disease: A Review
Dong, Y., Wu, X., Zhang, Y., Hu, A., Zhou, Q., Yue, X., Liu, Z., & Li, M. (2025) · Foods · doi:10.3390/foods14091531 · Cited by 19
“Insoluble fibrous protein aggregates cause damage to lipid membranes and neurotoxicity [129] and have been found on the surface of fungi and bacteria (such as Escherichia coli , Bacillus , Staphylococcus , and other gram-negative bacteria that usually trigger human diseases) [122,125,128,130].”
Microbiome Impact on Amyloidogenesis
Curto, J. S., Lopez, A. S., Sanchez, M. C., Tic, I., Fernández, M. R., & de Groot, N. S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.926702 · Cited by 13
“This seeding has been also detected between bacterial and host amyloid proteins (Friedland, 2015; Chen et al., 2016; Eisenberg and Sawaya, 2017).”
BackgroundSánchez-de-Lara-Sánchez, S., & Sánchez‐Pérez, A. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220615 · Cited by 15
“Bacterialamyloidcanactasaprion ‘protein’causingacross-seedingphenomenon,i.e., capableofinducingotherhostproteinstoform pathogenic (cid:2) -sheetstructure[66,67].”
Landau, M. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0118-0 · Cited by 12
Metabolomics in Otorhinolaryngology
Noto, A., Piras, C., Atzori, L., Mussap, M., Albera, A., Albera, R., Casani, A. P., Capobianco, S., & Fanos, V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.934311 · Cited by 14
“Identifying metabolic and microbial alterations is considered the new Rosetta Stone of medicine, an epigenetic determinant of human health status, which may help to unlock the obscure signs of several diseases (Ochoa-Reparaz et al., 2009; Noto et al., 2014; Friedland, 2015).”
BackgroundNeurodegenerative Disorders and the Gut-Microbiome-Brain Axis: A Literature Review
Dandamudi, B. J., Dimaano, K. A. M., Shah, N., AlQassab, O., Al-Sulaitti, Z., Nelakuditi, B., & Mohammed, L. (2024) · Cureus · doi:10.7759/cureus.72427 · Cited by 28
Johnson, A. M., Ou, Z.-Y. A., Gordon, R., & Saminathan, H. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106113 · Cited by 11
Influence of Gut Microbiota on Behavior and Its Disturbances
Ignatova, V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85317 · Cited by 16
“These products lead to forceful pro-inflammatory and innateimmune effects, activate the system Following enhanced amyloid aggregation, as well secondary degeneration occur, which are typical signs of AD, together with impaired cleansing mechanisms of Aβ peptide [17, 120, 121].”
BackgroundKrothapalli, M., Buddendorff, L., Yadav, H., Schilaty, N. D., & Jain, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126678 · Cited by 13
“…while there is a higher abundance of several bacteria such as Klebsiella , Escherichia , Streptococcus , Salmonella, and Pseudomonas species that secrete functional amyloid proteins with a demonstrated capacity to cross-seed and trigger a cascade of amyloid protein misfolding [109,110] (Figure 1).”
BackgroundAhmadi, S., Hasani, A., Khabbaz, A., Poortahmasebi, V., Hosseini, S., Yasdchi, M., Mehdizadehfar, E., Mousavi, Z. B., Hasani, R., Nabizadeh, E., et al. (2024) · Biogerontology · doi:10.1007/s10522-024-10136-4 · Cited by 13
Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12
Neta, F. I., de Souza, F. E. S., Batista, A. L., Pinheiro, F. I., Cobucci, R. N., & Gúzen, F. P. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220318092003 · Cited by 9
Sharifa, M., Ghosh, T., Daher, O. A., Bhusal, P., Alaameri, Y. A., Naz, J., Ekhator, C., Bellegarde, S. B., Bisharat, P., Vaghani, V., et al. (2023) · Cureus · doi:10.7759/cureus.47058 · Cited by 22
“Chronic inflammation has the potential to aggravate already-existing neurological diseases as well as play a role in the emergence of new ones [32,33].”
BackgroundButnaru, D., & Chapman, J. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.09.009 · Cited by 10
Thomas, C., Shilpa, B. M., & Mythri, R. B. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97546 · Cited by 10
Disease mechanisms as subtypes: Microbiome
Bonvegna, S., & Cilia, R. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00006-0 · Cited by 8
Oral Microbiome: Potential Link to Systemic Diseases and Oral Cancer
Vasquez, A. A., Ram, J. L., Qazazi, M. S., Sun, J., & Kato, I. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_9 · Cited by 13
Translational research into frailty from bench to bedside: Salivary biomarkers for inflammaging
Cárdenas, A. N., Bareke, H., Juanes‐Velasco, P., Landeira‐Viñuela, A., Hernández, Á., Montalvillo, E., Góngora, R., Arroyo-Anlló, E. M., Puente-González, A. S., Sánchez, R. M., et al. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.112040 · Cited by 9
“, misfolding of neuronal proteins through cross-seeding (Friedland, 2015).”
InfluentialOlfaction, among the First Senses to Develop and Decline
Brai, E., & Alberi, L. A. (2018) · InTech eBooks · doi:10.5772/intechopen.75061 · Cited by 16
Constipation and Cigarette Smoking Are Independent Influences for Parkinson’s Disease
Lehrer, S. P., & Rheinstein, P. H. (2022) · Cureus · doi:10.7759/cureus.21689 · Cited by 8
“Gut bacteria can produce proteins that have a similar structure to αsynuclein, so bacterial proteins might be providing a template for misfolding [12].”
BackgroundA role of human microbiota in the development of neurodegenerative diseases
Epishina, I. V., & Budanova, E. V. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212210157 · Cited by 12
Katsipis, G., Aivaliotis, M., & Pantazaki, Α. A. (2025) · Microorganisms · doi:10.3390/microorganisms13081875 · Cited by 7
“Flagella—and thus FliC—are particularly critical for adhesion to hydrophobic surfaces, as flagellated bacteria adhere more strongly to hydrophobic than hydrophilic substrates [91].”
A Review on the Nasal Microbiome and Various Disease Conditions for Newer Approaches to Treatments
Sarkar, S., Routhray, S., Ramadass, B., & Parida, P. K. (2022) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-022-03205-y · Cited by 9
Ataksik kedilerde fekal mikrobiyota transplantasyonu
Ural, K., ERDOĞAN, H., Halil İbrahim, A. D. A. K., ATEŞ, D. S., & KAHRAMAN, D. (2019) · Mehmet Akif Ersoy Üniversitesi Veteriner Fakültesi Dergisi · doi:10.24880/maeuvfd.460765 · Cited by 7
Khezri, M. R., Esmaeili, A., & Ghasemnejad‐Berenji, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00418 · Cited by 8
ApoE and mitochondrial dysfunction
Qin, L., Zhu, X., & Friedland, R. P. (2020) · Neurology · doi:10.1212/wnl.0000000000009569 · Cited by 7
Self-citationChen, Y., Wang, D., Liao, Y., Zuo, G., & Lu, X. (2024) · Discover Medicine · doi:10.1007/s44337-024-00135-2 · Cited by 6
Biofilm-associated proteins: from the gut biofilms to neurodegeneration
Valle, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2461721 · Cited by 7
Impact of amyloid-like ovalbumin fibril consumption on health-related markers: An in vitro approach
Luyckx, T., Grootaert, C., Delcour, J. A., Housmans, J. A. J., Rousseau, F., Schymkowitz, J. W. H., Carpentier, S., & Camp, J. V. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116288 · Cited by 5
Kerr, N. A., Bramlett, H. M., Sanchez‐Molano, J., Higueras, A. F., Walters, W. M., Vaccari, J. P. D. R., Keane, R. W., & Dietrich, W. D. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115269 · Cited by 6
Leng, S.-Y., Yang, Q., Yuan, Y., Chen, B., Chen, H., Ban, W., & Zhang, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1677896 · Cited by 6
“Studies have demonstrated that intraperitoneal LPS injection in mice accelerates the accumulation of A β in the hippocampus, resulting in cognitive impairments (Friedland, 2015).”
Metabolomics and Microbiomics: New Potential Strategies in Chronic Pain Syndrome
Piras, C., Pintus, B. M., Noto, A., Evangelista, M., Fanos, V., Musu, M., Mussap, M., Atzori, L., Sardo, S., & Finco, G. (2022) · Journal of Pain Research · doi:10.2147/jpr.s354516 · Cited by 6
Ageing and the gut-brain axis: lessons from the Drosophila model
Tan, F. H. P., Shamsuddin, S., & Zainuddin, A. (2023) · Beneficial Microbes · doi:10.1163/18762891-20230056 · Cited by 7
Gut Microbes: The Gut Brain Connection
Lynch, C. M. K., O’Riordan, K. J., Clarke, G. A., & Cryan, J. F. (2023) · Springer eBooks · doi:10.1007/978-3-031-46712-7_4 · Cited by 6
Trojans in Oral Environments: Evidence of Molecular Mimicry in Oral Immunity
Obando-Pereda, G. A. (2018) · InTech eBooks · doi:10.5772/intechopen.75747 · Cited by 5
Gut-Brain Axis: Probiotic Interactions and Implications for Human Mental Health
Gayathri, D., Vasudha, M., & Prashantkumar, C. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-1626-6_11 · Cited by 6
An Overview of Neurodegenerative Disorders
Mittal, P., & Agrawal, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_1 · Cited by 5
Golan, N., Parizat, A., Tabachnikov, O., Barnea, E., Olsen, W. P., Otzen, D. E., & Landau, M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108096 · Cited by 8
“Moreover, numerous studies have demonstrated that microbial amyloids can cross-seed and in-fl uence the formation of human amyloids, potentially contributing to neurodegenerative diseases such as Alz-heimer ’ s and Parkinson ’ s (57 – 63).”
Randhawa, S., Saini, T. C., Bathla, M., Teji, N., & Acharya, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00868 · Cited by 4
Halimi, H., Ahmadi, B., Asri, N., Rostami‐Nejad, M., & Houri, H. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107363 · Cited by 8
Fan, C. F., & Romero, J. R. (2016) · Internal Medicine Review · doi:10.18103/imr.v2i11.265 · Cited by 4
“The brain-gut axis is one of such mechanisms, which proposes that gastrointestinal and oral infections can increase the risk of neurodegeneration.[73] In support of this hypothesis prior reports have shown an association of the oral bacteria S.”
ResultPolifenollerin Bağırsak Mikrobiyota Kompozisyonunu Düzenleyici ve Nöroprotektif Etkileri
ÇİMEN, F., Kaya, H. P., & Ekici, L. (2020) · Akademik Gıda · doi:10.24323/akademik-gida.758838 · Cited by 7
“Alzheimer hastalarında, disbiyozis sonucu tetiklenen mukozal bozulma ile Gram (-) bakteri sayısında bir artış gözlenmektedir [94].”
BackgroundOuerdane, Y., El-Nahas, Z. S., Ouerdane, F., Hamam, K. M., & Ebada, M. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_12 · Cited by 4
Beneficial effect of ovocystatin on the cognitive decline in APP/PS1 transgenic mice
Stańczykiewicz, B., Jakubik, M., Rutkowska, M., Polanowski, A., Gburek, J., Gołąb, K., Juszczyńska, K., Trziszka, T., & Rymaszewska, J. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2018.08.002 · Cited by 4
A Review of the Relationship Between Gut Microbiota and Memory
Benmelouka, A. Y., Sherif, A., & Ebada, M. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_8 · Cited by 5
Lehrer, S. P., & Rheinstein, P. H. (2021) · PubMed · Cited by 12
The Double‐Edged Sword: The Complex Function of Enteric Glial Cells in Neurodegenerative Diseases
Mendonça, I. P., & Peixoto, C. A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70069 · Cited by 4
Roy, S., Chattopadhyay, D., Choudhury, L., Ghosh, S., & Mahajan, A. A. (2025) · Discover Neuroscience · doi:10.1186/s13064-025-00221-w · Cited by 6
“Template-cross-seeding through molecular mimicry might initiate neuronal protein misfolding in PD, resembling a prion disease-like mechanism [96].”
Ibrahim, M., Khalil, A. M., Attia, H., Alseekh, S., Mohamed, A. F., & El-Yamany, M. F. (2026) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10270-x · Cited by 3
“Therefore, pro-inflammatory bacterial products such as cytokines and LPS pass the impaired barrier into the blood, resulting in systemic inflammation (Buford 2017), BBB breakdown, and neurodegeneration (Friedland 2015; Zhou et al. 2020).”
THE EFFECT OF MICROBIOTA ON DISEASES
Çakmak, B., & İnkaya, B. V. (2021) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.808595 · Cited by 7
“Bağırsak Mikrobiyatası ve Nörolojik Hastalıklar Literatürde mikrobiyatanın depresyon, anksiyete ve nörodejenerasyon gibi pekçok nörolojik hastalığın patolojisine katkıda bulunduğu bildirilmektedir [33].”
Rajini, P. S., Bharath, M. M. S., & Muralidhara, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821039-0.00020-4 · Cited by 5
The gut microbiome as a factor in the development of Parkinson's disease
Арамайисовна, Б. Л., Poluektova, E. A., & Poluektov, M. G. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-1-90-96 · Cited by 4
Andreadou, E. G., Katsipis, G., Tsolaki, M., & Pantazaki, Α. A. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100091 · Cited by 3
Role of fungi in neurodegenerative diseases
Chaudhary, R., Kalra, R., & Goel, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821006-2.00006-6 · Cited by 3
Microbiota-Brain-Gut Axis and Neurodegenerative Disorders
Abughazaleh, S. J., Euers, L. A., & Quigley, E. M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00031-0 · Cited by 5
Collagen-binding Streptococcus Mutans Tied to Cerebral Microbleeds and Intracerebral Hemorrhage
Ihara, M., Tonomura, S., Yamamoto, Y., & Saitô, S. (2018) · Future Neurology · doi:10.2217/fnl-2018-0016 · Cited by 3
Perov, S., Lidor, O., Salinas, N., Golan, N., Tayeb-Fligelman, E., Deshmukh, M. G., Willbold, D., & Landau, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/493668 · Cited by 2
Aggregating gut: on the link between neurodegeneration and bacterial functional amyloidsPreprint
Wojciechowska, A. W., Wojciechowski, J. W., Zielińska, K., Söding, J., Kościółek, T., & Kotulska, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.26.624671 · Cited by 3
Gut microbiome: new diagnostic and treatment options
Mayev, I. V., & Lyamina, S. (2024) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2024-102-4-297-308 · Cited by 2
Gut microbiome and cognitive function in the Hispanic Community Health Study/Study of Latinos
Palacios, N., Gordon, S., Wang, T., Burk, R. D., Qi, Q., Huttenhower, C., González, H. M., Knight, R. D., DeCarli, C. S., Daviglus, M. L., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251376911 · Cited by 3
“…bacteria including the Klebsiella, Escherichia, Streptococcus, and Salmonella , Pseudomonas species secrete functional amyloid proteins with demonstrated capacity to cross-seed and trigger a cascade of amyloid protein misfolding 37,38 that can propagate from the gastrointestinal tract to the brain.”
The Microbiome Epoch: Cracking the Cardiovascular-Neurodegenerative Disorder Code
Parolini, C., & Amedei, A. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl47174 · Cited by 2
Sex Differences and Gut Microbiota Changes in Parkinson’s Disease
Lee, J., & Shin, C. M. (2022) · Springer eBooks · doi:10.1007/978-981-19-0120-1_24 · Cited by 2
The Role of Gut Microbiota-derived Short Chain Fatty Acids in Amyotrophic Lateral Sclerosis
Saadh, M. J., Dhiaa, S. M., Bansal, P., Dabis, H. K., Katyal, A., Saraswat, V., Ibrahim, A. A., Kadem, R. U., & Ubaid, M. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-024-00292-9 · Cited by 2
“These factors collectively contribute to the advancement of various neuropsychiatric, neurological, and neurodevelopmental disorders, particularly neurodegenerative conditions [36, 37].”
Bastian, F. O. (2015) · AIMS neuroscience · doi:10.3934/neuroscience.2015.4.240 · Cited by 1
Neurodegenerative Diseases and the Gut Microbiota
Cabré, S., O’Riordan, K. J., & Cryan, J. F. (2022) · Progress in inflammation research · doi:10.1007/978-3-030-91051-8_11 · Cited by 2
Gut–Brain Axis: Role of Gut Microbiota in Neurodegenerative Disease
Narang, A., & Sandhir, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_1 · Cited by 1
The bacterial OMP amyloids modulate α-synuclein and amyloid-β aggregation
Sulatsky, M. I., Belousov, M. V., Stepanenko, O. V., Stepanenko, O. V., Mikhailova, E. V., Fayoud, H. J., Nizhnikov, A. A., & Sulatskaya, A. I. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147485 · Cited by 2
Handajani, Y. S., Turana, Y., Hengky, A., & Kristian, K. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261415596 · Cited by 2
Silent Intruders: The Gut Virome in Brain Aging and Cognitive Decline
Silvestro, S., Midiri, A., Biondo, C., Casilli, S., Borrello, L., Zummo, S., & Mancuso, G. (2026) · Pathogens · doi:10.3390/pathogens15020180 · Cited by 2
“Some bacterial strains can produce functional extracellular amyloid fibers, such as E. coli , Salmonella enterica , Bacillus subtilis , Mycobacterium tuberculosis , and Staphylococcus aureus [71].”
Microbiota and Neurodegenerative Diseases
Khan, M. F., & Banerjee, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00098-x · Cited by 1
The role of the gut microbiota in Parkinson’s disease
Verugina, N. I., Levin, O. S., & Lyashenko, E. A. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112110286 · Cited by 1
Gut Microbiota in Elderly’s Health
Bäuerl, C., Selma‐Royo, M., Mera-Balseca, A. G., Collado, M. C., & Pérez‐Martínez, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_163 · Cited by 2
The gut microbiome in neurodegenerative disorders
Abughazaleh, S. J., Euers, L. A., & Quigley, E. M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821039-0.00006-x · Cited by 1
Linking diet and gut microbiota in multiple sclerosis
Bitarafan, S., Harirchian, M. H., Farahbakhsh, P., & Soltani, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00020-9 · Cited by 2
Parkinson's Disease, Diet and Gut Microbiota Alterations
Guach-Hevia, D. A. (2023) · Journal of Neurodegenerative Disorders · doi:10.36959/459/610 · Cited by 1
Precision Nutrition in Aging and Brain Health
Chen, S. T., & Small, G. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15315-0.00017-1 · Cited by 2
The Gut Microbiota and NDG: What Is the Interplay
Haiba, S., Idriss, S., & Awad, M. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_30-1 · Cited by 1
Gut Microbiota in Elderly’s Health
Bäuerl, C., Selma‐Royo, M., Mera-Balseca, A. G., Collado, M. C., & Pérez‐Martínez, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_163-1 · Cited by 1
(2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116257118 · Cited by 1
Palacios, N., Gordon, S., Wang, T., Burk, R. D., Qi, Q., Huttenhower, C., González, H. M., Knight, R. D., DeCarli, C. S., Daviglus, M., et al. (2024) · medRxiv · doi:10.1101/2024.05.17.24307533 · Cited by 1
Parkinson’s - Just another Infectious Disease
Dow, C. T. (2015) · Journal of Neuroinfectious Diseases · doi:10.4172/2314-7326.1000183
perspectives on the clean India campaign, the microbiota and ayurveda
Friedland, R. P. (2015) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.220302
Self-citationNanostructure Biomimetic Sensing and Energy Storage: Organic Memristor/Memcapacitors
Chen, E. T. (2014) · CRC Press eBooks · doi:10.1081/e-enn3-120054061
Dementia and Cerebrovascular Disease
Perini, G., Ramusino, M. C., Bernini, S., & Costa, A. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_29
The Gut Microbiome in Neurodegenerative Disorders
Euers, L. A., & Quigley, E. M. M. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190931544.013.11 · Cited by 1
Metadata
- Authors
- Friedland, R. P.
- Affiliations
- University of Louisville (US)
- Corresponding author
- Friedland, Robert P.
- ORCID
- Friedland, Robert P.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2015-03-18
- Volume
- 45
- Issue
- 2
- Pages
- 349-362
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1526611045
- Cited by
- 338
- References
- 129
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 31 · 2023: 30 · 2022: 52 · 2021: 49 · 2020: 35 · 2019: 25 · 2018: 24 · 2017: 24 · 2016: 13 · 2015: 10
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- University of Louisville
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- molecular mimicry, gut microbiota
- MeSH terms
- Animals, Humans, Cytokines, Molecular Mimicry, Neurodegenerative Diseases, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.